<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1235408/open_sms">Send us a text</a>What investors want to know about NASH development during the pandemic. Yasmeen Rahimi poses five questions NASH investors ask her about the impact of COVID-19 on NASH clinical and commercial development and our panelists provide answers in our second episode, FIVE $IMPLE PIECES: What investors want to know about NASH development during the pandemic.

Send us a text What investors want to know about NASH development during the pandemic. Yasmeen Rahimi poses five questions NASH investors ask her about the impact of COVID-19 on NASH clinical and commercial development and our panelists provide answers in our second episode, FIVE $IMPLE PIECES: What investors want to know about NASH development during the pandemic.

<a href="https://www.buzzsprout.com/twilio/text_messages/1235408/open_sms" rel="noopener noreferrer">Send us a text</a>What investors want to know about NASH development during the pandemic. Yasmeen Rahimi poses five questions NASH investors ask her about the impact of COVID-19 on NASH clinical and commercial development and our panelists provide answers in our second episode, FIVE $IMPLE PIECES: What investors want to know about NASH development during the pandemic.

Five $imple Pieces - Ep 2

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Science

Medicine

Health & Fitness

Natural Sciences

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Share Five $imple Pieces - Ep 2

Sign up to save your podcasts

Five $imple Pieces - Ep 2

Five $imple Pieces - Ep 2

More shows like Surfing the MASH Tsunami

Freakonomics Radio

Planet Money

Pivot

Diabetes Core Update

The School of Greatness

The Curbsiders Internal Medicine Podcast

The Daily

Up First from NPR

The Indicator from Planet Money

The Peter Attia Drive

All-In with Chamath, Jason, Sacks & Friedberg

Consider This from NPR

EASL Podcasts

Docs Who Lift

The Headlines